WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results
Keyword(s):
2015 ◽
Vol 21
(22)
◽
pp. 4989-4991
◽
2013 ◽
Vol 19
(14)
◽
pp. 3936-3943
◽
2009 ◽
Vol 15
(23)
◽
pp. 7412-7420
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 3006-3006
◽
2020 ◽
2014 ◽
Vol 2
(S3)
◽
2017 ◽
Vol 80
(3)
◽
pp. 591-598
◽